Member Info for Laura2022

What a ridiculous 1st post on SPI

Nearly as bad as big daddy and Stewarty this last 2mths (both filtered )

Chance of 2nd bidder imho

About 50,000 shares or less

Cav

As i keep saying ..juat filter and report rather than engage

Its quiet because most of the posters since Christmas were trolls like Stewart whom i green boxed

As I suggested to Kendall to do also

There were only ever 5% posters here who held

:)

Bently

Every LSE group has them

On SPI there were 3 accounts spending 6mths ONLY on SPI

Bassman and Satan have soent 12mths here !!

No where else 99% of the time

Saddos

Brilliant morbox

Makes you think all those accounts like Stewart who spent 5mths here and never posted ANYWHEREelse could have bought rather than troll

:)))

From SPI takeover

Coming here today from myself:)

Coming here :)

It was clear when Richard Grifiths was adding 3% via CFD

Profits to RCFX and IMM

Lovely profit for me from a £1.80 average

Took 3mths longer than thought but good job we didnt listen to Stewart and the other filtered users here

250p

to a potential sale of the Company, the Board confirms that it has received a non-binding proposal (the "Proposal") from funds advised by Toscafund Asset Management LLP ("Toscafund"), the Company's second largest shareholder, regarding a possible cash offer of 250 pence per Spire Healthcare share for the entire issued and to be issued ordinary share capital of Spire Healthcare (the "Possible Cash Offer"). The Proposal includes an option for Spire Healthcare shareholders to elect for an unlisted rollover equity alternative in respect of some or all of their Spire Healthcare shares

Some of the comments from the company at that presentation

" there were 3 big clients months ago now 5 or 6 and by end of year we had 16. Space deal part two very close now. Extreme growth over next few years. Team now streamlined and all clicking into place "

Anything above 4.25p was a buy today

RC Fornax (RCFX) is experiencing strong growth in early 2026, driven by new defence contracts and a £5.1M sales pipeline, leading to a 16% share price jump in late March. The company is seeing demand for its outcome-based engineering, with a 40% sales growth forecast for FY26 as of February. Key recent news highlights:Financial & Operational Growth: As of April 2026, RCFX has surpassed last year’s total revenue in just seven months, focusing on a robust £5.1M sales visibility against a £5.8M forecast.Defence Sector Momentum: Recent wins include acceptance onto a major UK Defence Framework and contract extensions with tier-1 clients.Strategy Shift: The company is undergoing a transformation, with new Board members, a renewed sales process, and a focus on SME procurement,

Hi memyself

Easily above 15p ( large overhang from outgoing COO was cleared 4 weeks ago...

Very good recent presentation too

86kb

Rcfx :)

Oops

Will only allow 10,000

Lets add another 13,000

Rude not to after such a good day :)

At 0.6p mid price PYC is 50%+ above the placing price in just 6 weeks

And also £1.4mln potential contracts due according to presentation

With just a £2.5 mln cap and only 450mln shares ( many bio tech peers have 1.5-2.5bln shares eg apta gdr etc) and with £650,000 from the recent investment and c £200-300k left from before that is nearly 50% pf market cap in cash

MPL profits